India’s Transformative Journey Under PM Modi’s Leadership: Insights from JP Nadda

News18 India’s Prestigious Summit: A Gathering of India’s Brightest Minds The Eighth Edition of News18 India Chaupal In a captivating display of intellect and foresight, India’s leading Hindi news channel, News18 India, orchestrated the eighth edition of its prestigious flagship summit, News18 India Chaupal. This grand event unfolded at the opulent ITC Maurya in Delhi…

Read More

Avery Dennison Q4 Earnings Exceed Expectations, Increase Year-Over-Year on Strong Volumes

AVY Expects Strong Earnings Growth in 2025 As a company that prides itself on being prossionally run, educated in the market, profit focused, and intense in its pursuit of success, AVY’s latest earnings forecast for 2025 has sent shockwaves through the business world. The company expects adjusted earnings per share of $9.80-$10.20, signaling a significant…

Read More

Exclusive: Chinese Citizen Attempts to Enter Mar-a-Lago, Claims to Have Information on Trump Shooting – Report

A Chinese Citizen Arrested After Trying to Enter Mar-a-Lago The Incident A Chinese citizen was reportedly arrested after police said he tried multiple times to enter former President Donald Trump’s Mar-a-Lago club in Florida, claiming he had documents linking China to the July 13 assassination attempt in Butler, Pennsylvania. Zijie Li, 38, of El Monte,…

Read More

Unveiling the Power of ALAUNOS Therapeutics: A Look into their Revolutionary HUNTR TCR Discovery Platform at the Society for Immunotherapy of Cancer’s 2022 Annual Meeting

Alaunos Therapeutics to Present Data High… Data supports high-throughput screening process to identify neoantigen-reactive TCRs Exclusive ownership of discovered KRAS mutation-reactive TCRs hunTR enables expansion of the Company’s hotspot mutation targeted TCR library HOUSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) — Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company…

Read More